grey market semaglutide Size, Share & Trends Report, 2025-2035 Will Compounded Semaglutide Be Banned?

10.1096/fj.201801417R FASEB J

Researchers investigating musculoskeletal pain, tendon repair, and bone healing have noted the overlapping benefits that extend to neural tissue, since the inflammatory and regenerative pathways share common molecular ground

In 2020, an estimated 595 million individuals were afflicted with OA, representing 7.6% of the global population, with a 132.2% increase in the total number of cases since 1990 [2]

It sits in a regulatory grey area as a cosmetic product, not a medicine

By improving gut health, increasing microbial diversity, and boosting SCFA production, we can help the body make and respond to GLP-1 in a more natural way